Malvern Pennsylvania based VenatoRx Pharmaceuticals is raising $59,999,999.00 in New Equity Investment.
Malvern, PA – According to filings with the U.S. Securities and Exchange Commission, VenatoRx Pharmaceuticals is raising $59,999,999.00 in new funding. Sources indicate as part of senior management President, Christopher Burns played a key role…